Contraview Platform
A multi-LLM based biotech AI analyst leveraging the power of carefully procured databases and autonomous agents
Key components
01
End-to-end company analysis
We use information provided by the user or by publicly listed companies to run our analysis on the company. This analysis is powered by our Contraview AI Engine which analyzes and assesses information provided to us.
This process enables us to come up with precise scorings of company’s potential and detailed analysis with claims on its trajectory development.
02
Contraview AI Engine
We use our proprietary Contraview multi-LLM and multi-agent systems to run diagnostics on all available information as well as information that we collect ourselves to enrich the analysis and turn it into a work of art.
Our Engine is powered by a Data Foundation, which consists of many datasets that we have created and are constantly enriching in order to enhance the analysis and keep it up to date at all times. As a result, our users can be certain that the analytical product they receive is the result of complex analytical processes and extensive model training on relevant data.
03
Knowledge exploration
We provide our users with our Contraview AI Assistant to enhance user experience and help our clients to obtain even more value from our industry analysis and knowledge.
This assistant has access to the user's previously provided and generated information, as well as our knowledge databases. Users can interact with it by asking relevant questions about the analysed companies or the industry, or by feeding it more data to improve its analysis.
03Capabilities
What ContraNova does
Advanced AI-driven Analysis
ContraNova scores every biotech company on its odds of being acquired. In a backtest on 2019 to 2022, companies it ranked in the top 10% were acquired for $100M or more within three years at nearly 3x the base rate (AUC 0.74), using only information public at the time.
Comprehensive Market Intelligence
One system covers 24,000+ companies, public and private, from seed to big pharma: 37,000+ drug programmes, 76,000 clinical trials, 80,000 financing and deal records back to 1980, and 44,000 executives, founders and board members.
Time and Resource Efficiency
The engine tracks 2,800 variables per company and refreshes them every night. Questions that used to take an analyst a week of reading come back in minutes, with every number tied to its source.
Specialized Databases for Precision
ContraNova reads at evidence level, not headline level: 187,000 scientific papers, 7,500 drug targets, 274,000 searchable passages of trial, programme and company text, and 328,000 drug-versus-control effect results from clinical trials. Each result stays tied to the trial arm and timepoint where it was measured.
Insights for Informed Decision-Making
Every score ships with its evidence: the inputs that moved it, how much data sits behind it, and what is missing. Our acquisition model holds up from 12 to 36 months in tests on years it never saw, and no model is served until it passes a leak audit.
Competitive Edge
Most tools show what already happened. ContraNova is built to show what happens next: who reads out first, which mechanisms have failed before, and who is likely to buy. It is used day to day on live venture deals, and we are building it with funds.
Data protection & Privacy
At Contraview, we take data protection and privacy very seriously. We understand that when you provide us with your company's pitch, you are entrusting us with sensitive information, and we want to assure you that your data is safe with us.
By entrusting us with your company's information, you can be confident that we are committed to protecting your privacy and using your data only for the purpose of providing you with valuable insights and analysis. Your trust means everything to us, and we are dedicated to upholding the highest standards of data protection and privacy.
AI Model
Our AI-based tool is designed to provide you with accurate and valuable company analysis without compromising the privacy of your data. Our AI model is trained to only extract relevant information for the purpose of company analysis, and we do not use your data for any other purposes.
Data Collection and Storage
When you submit your company's pitch, we collect and store the necessary information to conduct a thorough analysis. Your data is securely stored on our servers with strict access controls and encryption measures to protect it from unauthorized access.
Data Transfer
We understand the importance of secure data transfer, and we use industry-standard encryption protocols to ensure that your data is safely transferred to our platform for analysis. We do not share your data with any third parties without your explicit consent.